Stock listing

OTC:BLPH Bellerophon Therapeutics Inc Stock

Follow Bellerophon Therapeutics Inc into a list and get an email when it puts out news.

Delisted OTC:BLPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:BLPH
Asset type
Stock
Exchange
OTC
Currency
USD

Bellerophon Therapeutics Inc on 6ix

Decks
9 decks · latest Jun 5, 2023

Decks

DeckKindSlidesDate
Technical Presentation (June 2023)Technical9 slidesJun 5, 2023
Investor Presentation (January 2022)Investor deck25 slidesJan 5, 2022
Investor Presentation (January 2021)Investor deck32 slidesJan 11, 2021
Corporate Update (March 2020)Corporate update16 slidesMar 31, 2020
Technical Presentation (December 2019)Technical10 slidesDec 17, 2019
Investor Presentation (January 2019)Investor deck29 slidesJan 7, 2019
Investor Presentation (October 2018)Investor deck30 slidesOct 16, 2018
Investor Presentation (September 2018)Investor deck30 slidesSep 5, 2018
Technical Presentation (September 2015)Technical18 slidesSep 25, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniel Tassé
Other companies: DBV Technologies SA (Chief Executive Officer · Since at least Jan 1, 2021); Regenxbio Inc. (Independent Board Member · Since at least Aug 15, 2016); Mallinckrodt Inc (Interim Pres-Hospital Business · May 1, 2015 – May 1, 2015 · Past)
Director · Feb 13, 2015 – Jun 21, 2018 · Past
Jonathan M Peacock
Other companies: Avantor, Inc. (Director · May 16, 2019 – May 8, 2025 · Past); Kite Pharma Inc (Director · Jun 19, 2014 – Oct 3, 2017 · Past); Amgen Inc. (EVP & CFO · Apr 25, 2013 – Oct 28, 2013 · Past)
Director · Feb 13, 2015 – Mar 31, 2021 · Past
Theodore T Wang
Other companies: MariaDB plc (Director · Dec 16, 2022 – Jun 29, 2023 · Past); Angel Pond Holdings Corp (Chief Executive Officer, Director · May 6, 2021 – Dec 16, 2022 · Past); ChronoScale Corporation (Director · Nov 10, 2020 – Nov 10, 2020 · Past)
Director · Apr 26, 2021 – Jun 7, 2023 · Past
Andre V Moura
Other companies: Avantor, Inc. (Director · May 16, 2019 – May 16, 2019 · Past)
Director · Apr 28, 2016 – Sep 10, 2020 · Past
Naseem Amin
Other companies: Avadel Pharmaceuticals PLC (Director · Since at least May 17, 2024)
Director · Jun 29, 2015 – Jun 7, 2023 · Past
Amit AgrawalChief Operating Officer · Jul 8, 2015 – Jul 8, 2015 · Past
Amy EdmondsVP Clinical Operations & Admin · May 22, 2019 – Sep 26, 2019 · Past
Deborah QuinnChief Medical Officer · Oct 21, 2015 – Jun 12, 2018 · Past
Fabian TenenbaumChief Executive Officer, Director · Feb 29, 2016 – Nov 15, 2019 · Past
Martin DekkerSee Remarks · Jan 19, 2016 – Jun 7, 2023 · Past
All 16 people
PersonSeat
Matthew BennettDirector · Mar 22, 2018 – Sep 10, 2020 · Past
Nicholas LacconaFINANCIAL OFFICER, (PFO & PAO) · Sep 30, 2021 – Feb 10, 2023 · Past
Parag Suresh ShahVP of Business Operations · Apr 6, 2016 – Jun 7, 2023 · Past
Peter FernandesSee Remarks · May 18, 2015 – Jun 7, 2023 · Past
Scott P BruderDirector · Feb 10, 2023 – Jun 7, 2023 · Past
Wassim FARESChief Medical Officer · Sep 10, 2020 – Sep 10, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about Bellerophon Therapeutics Inc.